PortfoliosLab logoPortfoliosLab logo
Rezolute, Inc. (RZLT)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US76200L3096
CUSIP
76200L309
IPO Date
May 1, 2014

Highlights

Market Cap
$316.25M
Enterprise Value
$306.25M
EPS (TTM)
-$0.84
Gross Profit (TTM)
-$8.00K
EBITDA (TTM)
-$62.55M
Year Range
$1.07 - $11.46
Target Price
$7.86
ROA (TTM)
-60.76%
ROE (TTM)
-65.80%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Rezolute, Inc.

Often compared with RZLT:
RZLT vs. NESR

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Rezolute, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Rezolute, Inc. (RZLT) has returned 29.24% so far this year and 5.17% over the past 12 months. Over the last ten years, RZLT has returned -25.45% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


Rezolute, Inc.

1D
7.02%
1M
-4.98%
YTD
29.24%
6M
-67.55%
1Y
5.17%
3Y*
16.68%
5Y*
-15.72%
10Y*
-25.45%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since May 1, 2014, RZLT's average daily return is +0.32%, while the average monthly return is +1.67%. At this rate, your investment would double in approximately 3.5 years.

Historically, 41% of months were positive and 59% were negative. The best month was Jul 2020 with a return of +269.9%, while the worst month was Dec 2025 at -75.7%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 8 months.

On a daily basis, RZLT closed higher 36% of trading days. The best single day was Jan 7, 2019 with a return of +250.0%, while the worst single day was Dec 11, 2025 at -87.2%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202641.53%-3.89%-4.98%29.24%
20257.14%-15.62%-34.54%29.66%9.57%8.25%33.41%19.66%32.02%-0.85%4.29%-75.72%-51.84%
202410.83%50.00%54.55%5.10%50.37%6.70%6.86%3.59%1.89%12.99%-8.03%-2.78%393.70%
202324.15%-3.50%-22.58%8.59%2.16%-7.04%-5.56%-22.99%-8.33%-28.03%-18.74%28.56%-52.05%
2022-4.60%-42.76%29.50%12.43%-26.32%15.36%-3.10%-23.96%15.13%-38.32%-2.37%25.45%-56.69%
202133.19%-27.99%-38.61%-5.10%54.18%38.14%-21.97%-17.02%-19.06%-14.42%-20.62%-5.91%-60.13%

Benchmark Metrics

Rezolute, Inc. has an annualized alpha of 111.84%, beta of 0.55, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since May 02, 2014.

  • This stock participated in 222.45% of S&P 500 Index downside but only 58.38% of its upside — more exposed to losses than it benefited from rallies.
  • Beta of 0.55 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
111.84%
Beta
0.55
0.00
Upside Capture
58.38%
Downside Capture
222.45%

Return for Risk

Risk / Return Rank

RZLT ranks 56 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


RZLT Risk / Return Rank: 5656
Overall Rank
RZLT Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
RZLT Sortino Ratio Rank: 7171
Sortino Ratio Rank
RZLT Omega Ratio Rank: 8686
Omega Ratio Rank
RZLT Calmar Ratio Rank: 4141
Calmar Ratio Rank
RZLT Martin Ratio Rank: 4141
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Rezolute, Inc. (RZLT) and compare them to a chosen benchmark (S&P 500 Index).


RZLTBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.04

0.90

-0.86

Sortino ratio

Return per unit of downside risk

1.68

1.39

+0.29

Omega ratio

Gain probability vs. loss probability

1.35

1.21

+0.14

Calmar ratio

Return relative to maximum drawdown

0.05

1.40

-1.35

Martin ratio

Return relative to average drawdown

0.10

6.61

-6.51

Explore RZLT risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Rezolute, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Rezolute, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Rezolute, Inc. was 99.63%, occurring on Nov 29, 2023. The portfolio has not yet recovered.

The current Rezolute, Inc. drawdown is 98.48%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.63%May 5, 20142397Nov 29, 2023

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Rezolute, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Rezolute, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for RZLT in comparison with other companies in the Biotechnology industry. Currently, RZLT has a P/B value of 2.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items